compound heterozygous mutations associated with autophagic impairment cause cerebral infarction in Pompe disease.

Clicks: 287
ID: 101043
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #21 of 29 articles by views in Aging

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Clinical manifestations of the late-onset adult Pompe disease (glycogen storage disease type II) are heterogeneous. To identify genetic defects of a special patient population with cerebrovascular involvement as the main symptom, we performed whole-genome sequencing (WGS) analysis on a consanguineous Chinese family of total eight members including two Pompe siblings both had cerebral infarction. Two novel compound heterozygous variants were found in GAA gene: c.2238G>C in exon 16 and c.1388_1406del19 in exon 9 in the two patients. We verified the function of the two mutations in leading to defects in GAA protein expression and enzyme activity that are associated with autophagic impairment. We further performed a gut microbiome metagenomics analysis, found that the child's gut microbiome metagenome is very similar to his mother. Our finding enriches the gene mutation spectrum of Pompe disease, and identified the association of the two new mutations with autophagy impairment. Our data also indicates that gut microbiome could be shared within Pompe patient and cohabiting family members, and the abnormal microbiome may affect the blood biochemical index. Our study also highlights the importance of deep DNA sequencing in potential clinical applications.
Reference Key
jia2020aging Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jia, Xiaodong;Shao, Libin;Liu, Chengcheng;Chen, Tuanzhi;Peng, Ling;Cao, Yinguang;Zhang, Chuanchen;Yang, Xiafeng;Zhang, Guifeng;Gao, Jianlu;Fan, Guangyi;Gu, Mingliang;Du, Hongli;Xia, Zhangyong;
Journal Aging
Year 2020
DOI
10.18632/aging.102879
URL
Keywords
cerebral infarction pompe disease gaa mutation gut microbiome metagenomics

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.